Company Overview and News

 
VINCI : QUARTERLY INFORMATION AT 31 MARCH 2018

2018-04-26 globenewswire
Business indicators for the first quarter of 2018, despite adverse weather conditions in Europe, confirm the positive trends seen in 2017 and support the Group's forecasts of higher revenue and income for the full year.

 
VINCI : INFORMATION TRIMESTRIELLE AU 31 MARS 2018

2018-04-26 globenewswire
Les données d'activité du premier trimestre 2018, en dépit de conditions climatiques difficiles en Europe, confirment les bonnes tendances observées en 2017 et confortent la perspective de hausses du chiffre d'affaires et des résultats du Groupe pour l'ensemble de l'année.

 
NSW uni course with no exams or lectures named among top four in the world by MIT

2018-03-28 smh.com.au
They don't sit a single exam throughout their degree and instead of lectures, engineering students at Charles Sturt University have Netflix-style on-demand classes.

 
NSW uni course with no exams or lectures named among top four in the world

2018-03-28 smh.com.au
They don't sit a single exam throughout their degree and instead of lectures, engineering students at Charles Sturt University have Netflix-style on-demand classes.

 
Seymour Whyte calls for halt

2017-09-28 proactiveinvestors.com.au
Seymour Whyte Ltd (ASX:SWL) has been granted a trading halt by the ASX, with its shares placed in pre-open.

 
'Widen the Western Freeway' says state's biggest engineering companies

2017-05-22 smh.com.au
The people of Brisbane should demand the Queensland government widen the Western Freeway in next month's state budget to make the $1.5 billion Legacy Way tunnel at Toowong work more efficiently, Queensland's biggest engineering firms say.

 
Mining surge offsets fall in banks to lift ASX

2017-03-16 theage.com.au
In a session dominated by central bank policy, the local sharemarket initially surged higher after the US Federal Reserve flagged a cautious approach to rate rises this year, only to trim gains after a surprise follow-up move by the People's Bank of China.

 
Mining surge offsets fall in banks to lift ASX

2017-03-16 smh.com.au
In a session dominated by central bank policy, the local sharemarket initially surged higher after the US Federal Reserve flagged a cautious approach to rate rises this year, only to trim gains after a surprise follow-up move by the People's Bank of China.

 
SWL Market Update

2016-05-13 asx.com.au

 
Forfeiture of Employee Options

2016-04-07 asx.com.au

 
Appendix 3B

2016-04-07 asx.com.au

 
Half Yearly Report and Accounts

2016-02-24 asx.com.au

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...